Atossa Therapeutics, Inc. (ATOS)
5.74
-0.06
(-1.03%)
USD |
NASDAQ |
May 07, 16:00
5.74
0.00 (0.00%)
After-Hours: 20:00
Atossa Therapeutics SG&A Expense (TTM) : 15.96M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Celldex Therapeutics, Inc. | 43.84M |
| Plus Therapeutics, Inc. | 12.13M |
| Abeona Therapeutics, Inc. | 65.03M |
| Cell Source, Inc. | 1.942M |
| Kiora Pharmaceuticals, Inc. | 5.745M |